-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the evening of April 26, Kasai Bio released its first quarterly report for 2021
In terms of research and development, the announcement showed that Kasai Bio's research and development expenses in the first quarter were 27.
Kasai Bio said that the company's development strategy includes three priorities: developing new bio-based materials with large-scale application scenarios, especially thermoplastic fiber-reinforced composite materials
According to reports, at present, Cathay's bio-based long-chain dibasic acid products occupy a leading position in the world, with a bio-based pentamethylene diamine production line with a production capacity of 50,000 tons/year and a bio-based polyamide (nylon) with a production capacity of 100,000 tons/year.